Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.

Su LD, Schnitzer B, Ross CW, Vasef M, Mori S, Shiota M, Mason DY, Pulford K, Headington JT, Singleton TP.

J Cutan Pathol. 1997 Nov;24(10):597-603.

3.

The t(2;5) in human lymphomas.

Kadin ME, Morris SW.

Leuk Lymphoma. 1998 Apr;29(3-4):249-56. Review.

PMID:
9684923
5.

Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.

Beylot-Barry M, Lamant L, Vergier B, de Muret A, Fraitag S, Delord B, Dubus P, Vaillant L, Delaunay M, MacGrogan G, Beylot C, de Mascarel A, Delsol G, Merlio JP.

Am J Pathol. 1996 Aug;149(2):483-92.

7.
8.

High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.

Lamant L, Meggetto F, al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiuta M, Mori S, Delsol G.

Blood. 1996 Jan 1;87(1):284-91.

9.

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.

Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.

Blood. 1996 Sep 1;88(5):1771-9.

10.

Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations.

Beylot-Barry M, Groppi A, Vergier B, Pulford K, Merlio JP.

Blood. 1998 Jun 15;91(12):4668-76.

11.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798
12.

Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.

Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.

Leukemia. 2000 Sep;14(9):1533-59. Review.

PMID:
10994999
13.

Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.

Nakamura S, Shiota M, Nakagawa A, Yatabe Y, Kojima M, Motoori T, Suzuki R, Kagami Y, Ogura M, Morishima Y, Mizoguchi Y, Okamoto M, Seto M, Koshikawa T, Mori S, Suchi T.

Am J Surg Pathol. 1997 Dec;21(12):1420-32.

PMID:
9414185
14.

Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.

Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY.

Blood. 1997 Feb 15;89(4):1394-404.

15.

Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.

Cataldo KA, Jalal SM, Law ME, Ansell SM, Inwards DJ, Fine M, Arber DA, Pulford KA, Strickler JG.

Am J Surg Pathol. 1999 Nov;23(11):1386-92.

PMID:
10555007
16.

Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.

Sherman CG, Zielenska M, Lorenzana AN, Pulford KA, Mason DY, Hutchison RE, Thorner PS.

Pediatr Dev Pathol. 2001 Mar-Apr;4(2):129-37.

PMID:
11178628
17.

Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.

Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S.

Blood. 1995 Sep 1;86(5):1954-60.

18.
19.

The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.

Dirks WG, Zaborski M, Jäger K, Challier C, Shiota M, Quentmeier H, Drexler HG.

Leukemia. 1996 Jan;10(1):142-9.

PMID:
8558920
20.

The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases.

Kapur S, Tiemann M, Menke MA, Schubert C, Parwaresch R.

Indian J Med Res. 2005 Jan;121(1):46-54.

PMID:
15713979

Supplemental Content

Support Center